ArticleActa pharmacologica Sinica2017

Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.

Jing-Jing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.